Invesco
DMAC icon

Invesco’s DiaMedica Therapeutics DMAC Stock Holding History

Invesco’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$139K Sell
19,704
-5,095
-21% -$31.3K ﹤0.01% 3683
2026
Q1 		$168K Buy
24,799
+6,171
+33% +$48.9K ﹤0.01% 3529
2025
Q4 		$148K Buy
18,628
+4,293
+30% +$32.1K ﹤0.01% 3592
2025
Q3 		$98.5K Buy
14,335
+450
+3% +$2.44K ﹤0.01% 3686
2025
Q2 		$54.2K Buy
+13,885
New +$54.1K ﹤0.01% 3719

Other funds holding DMAC

Cooperman Leon G
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco's DMAC Position: Q2 2026 in Review

Invesco reduced its DiaMedica Therapeutics (DMAC) stake by 21% in Q2 2026, selling an estimated $31.3K and leaving 19,704 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #3683.

Invesco first reported a position in DMAC in Q2 2025 and has held it in 5 quarters since. The position peaked at $168K in Q1 2026. 88 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • Invesco held 19,704 shares of DiaMedica Therapeutics worth $139K as of Q2 2026.
  • Invesco sold 5,095 DiaMedica Therapeutics shares in Q2 2026, an estimated $31.3K.
  • DiaMedica Therapeutics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3683 holding.
  • Invesco first reported a position in DiaMedica Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Invesco's DiaMedica Therapeutics position peaked at $168K in Q1 2026.
  • 88 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.